<DOC>
	<DOCNO>NCT00100074</DOCNO>
	<brief_summary>To assess safety tolerability 7.5 , 15 30 mg sublingual lobeline .</brief_summary>
	<brief_title>To Assess Safety Tolerability 7.5 , 15 30 mg Sublingual Lobeline . - 1</brief_title>
	<detailed_description>The primary objective study characterize pharmacokinetics three ascend dos lobeline normal volunteer .</detailed_description>
	<mesh_term>Amphetamine-Related Disorders</mesh_term>
	<mesh_term>Lobeline</mesh_term>
	<criteria>Healthy individual body mass index 18 30 . Willing able give write consent . Must negative drug test Females must negative pregnancy test prior study drug administration Must medical contraindication determine routine test Please contact site information</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2004</verification_date>
</DOC>